GL1X · GenesisL1 explorer

Research workbench

Structure of rorgt in complex with a novel isoquinoline inverse agonist.

Analyse Structure of rorgt in complex with a novel isoquinoline inverse agonist. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6BR2
Type
protein
Length
427 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
E3S
Pockets
6 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 65% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein21565% helix, 5% strandP51449
BNuclear receptor ror-gammaprotein21266% helix, 5% strandP51449

Ligands and binding sites

  • E3S · (1R)-N-(4-tert-butyl-3-fluorophenyl)-6-methoxy-2-[(3-oxo-2,3-dihydro-1,2-oxazol-5-yl)acetyl]-1,2,3,4-tetrahydroisoquinoline-1-carboxamide · ligand · 2 copies · chains A, B
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14050.780.8637E3S
23530.760.8636E3S
32680.480.7228empty
4690.380.7914empty
5530.340.7812empty

Interfaces

1 interface between chains.

  • A–B · 215 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 6BR2 · Structure of RORgt in complex with a novel isoquinoline inverse agonist. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.